neurofibromatosis (central) type 2

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • the most common such syndrome with multiple schwannomas

Pathology

Genetics

Clinical manifestations

Laboratory

PCR/southern blot

Radiology

More general terms

Additional terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 175
  2. UniProt http://www.uniprot.org/uniprot/P35240.html
  3. Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
  4. Coy S, Rashid R, Stemmer-Rachamimov A, et al. An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol. 2020;139:643-665. PMID: https://pubmed.ncbi.nlm.nih.gov/31161239

Patient information

neurofibromatosis type-2 patient information

Database